Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trulieve Cannabis Corp C.TRUL

Alternate Symbol(s):  C.TRUL.NT.U | TCNNF

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Its three regional hubs are anchored by market positions in cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.


CSE:TRUL - Post by User

Post by Bullknit101on Jan 23, 2022 9:15am
283 Views
Post# 34349565

2022 Trends

2022 TrendsThere are some saying that all lower tier (2,3,4) operators will dissappear. I disagree. The ones that are cash flow positive and fulfill a craft or niche market will be around for a while. Also, there will be a push toward biosynthetic minor cannabinoids as more studies reveal how powerful these compounds are for various health conditions. Also, the production of THC and CBD has a massive carbon footprint along with massive water usage whereas biosynthesis production is a fraction of what plant growers use. But definitely most will still want CBD and THC directly from the plant. The minor cannabinoids are not economical to get from the plant. Trulieve is offering CBN and certainly we'll see more minor cannabinoids this year.
<< Previous
Bullboard Posts
Next >>